1
/
of
0
FDA Drug Approval, N006488, XYLOCAINE W/ EPINEPHRINE
FDA Drug Approval, N006488, XYLOCAINE W/ EPINEPHRINE
Regular price
$49.00 USD
Regular price
Sale price
$49.00 USD
Unit price
/
per
NDA: 006488
Company: FRESENIUS KABI USA
Drug Name: XYLOCAINE W/ EPINEPHRINE
Active Ingredients: EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Strength: 0.005MG/ML;2%
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 11/19/1948
Marketing Status: Prescription
Submission Classification:
Company: FRESENIUS KABI USA
Drug Name: XYLOCAINE W/ EPINEPHRINE
Active Ingredients: EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Strength: 0.005MG/ML;2%
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 11/19/1948
Marketing Status: Prescription
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details